136
Views
0
CrossRef citations to date
0
Altmetric
Articles

Two new flavonoid thioglucosides from the seeds of Lepidium apetalum

, , , , , , , & show all
Pages 976-982 | Received 01 Nov 2022, Accepted 09 Mar 2023, Published online: 22 Mar 2023
 

Abstract

Two previously undescribed flavonoid thioglucosides lepidiumflavonosides A and B (1–2) and two known megastigmane compounds (7E,9S)-9-hydroxy-5,7-megastigmadien-4-one 9-O-β-D-glucopyranoside (3) and (9S)-4-oxo-β-inol β-D-glucopyranoside (4) were isolated from the water extract of the seeds of Lepidium apetalum Willd. The structural elucidation of isolated compounds was unambiguously determined based on extensive 1D and 2D NMR spectroscopic analyses. All compounds were evaluated for their estrogen-like effects on MCF-7 cells in vitro. The results showed that compounds 1–4 significantly promoted the proliferation of MCF-7 cells, and the proliferation was antagonized by the specific ER antagonist ICI182,780, suggesting that compounds 1–4 might have the estrogen-like effect in vitro potentially.

Graphical Abstract

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

This research was funded by the National Basic Research Program of China [2019YFC1708802], National Natural Science Foundation of China [82104386], the Scientific and Technological Key Project in Henan Province [212102310345], and the Special Project of Scientific Research on Traditional Chinese Medicine in Henan [20-21ZY2151].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.